This project intended to assess the impact of miR-27a on the cytotoxicity of mepivacaine on BCC via in vitro experiments, and whether it exerted a part via modulating the IRE1-TRAF2 signaling pathway was further analyzed to offer a theoretical basis for clinical treatment of BC patients. This evidence concerns the gene ERN1 and breast cancer.